Life Sciences

FDA warns Abbott for misleading promotion

Pharma Compliance Alert, February 4, 2009

Abbott Laboratories’ flashcard for Depakote and Depakote ER misbrands the drugs, according to an FDA warning letter posted January 29.

Post a Comment

Name:

 

E-mail:

 

Please enter your comment below:

   

Please enter the text below:

   
   

Most Popular